Therefore, several factors should be incorporated into our consideration in the future analysis, including standardization of microbiome sequencing approaches, analysis of metabolomic profiling and other methods to improve the efficiency of next-generation probiotics. Prebiotics Prebiotics, defined as fermentable, non-digestible chemicals or substrates which promote the growth of selective group of microorganisms and thereby a diverse and healthy microbiota, are another means of targeted microbiome modulation.57 The purpose of prebiotics administration is to confer a selective advantage to beneficial members of the microorganisms compared to the direct use of microbiotics. are essential for the efforts in expanding immunotherapy efficacy. This review Necrostatin 2 S enantiomer summarizes latest knowledge about the interactions between microbiome, host immunity and cancer, and strategies to modulate the microbiome with implications to be translated into clinic. Funding This study was supported by?National Key R&D Program of China?(No.?2020YFA0509200/2020YFA0509203),?RGC Theme-based Res Scheme Hong Kong?(T21-705/20-N). levels were associated with the IFN-I pathway and T cell responses, suggesting that may become a probiotic as a therapeutic strategy for HIV.6 Gut microbiome and adaptive immunity In the largest proportion of the human immune system, gut-associated lymphoid tissues (GALT), which include the lamina propria and Peyer’s patches (PP), triggering of PRRs expressed both on cell surface and inside the cell are capable of inducing the functional maturation of (dendritic cells) DCs and priming of na?ve T cells and B cells, and thus coupling innate and adaptive immunity.7 Luminal antigens are sampled directly by DCs through extension of dendrites (membrane extensions) between epithelial cells, or indirectly by endocytosis of specialized antigen-sampling cells (called M cells) via transcytosis relatively intact Necrostatin 2 S enantiomer to DCs and macrophages. After being primed, naive T and B cells are differentiated into T regulatory (Treg) cells or effector T cells and IgA-producing plasma cells which migrate from the efferent lymph vessels of the GALT to the mesenteric lymph nodes (mLN), and finally to peripheral blood via the thoracic duct and therefore involving in host systemic immunity.8 Pinacho et al. reported that the abundance of the genus Prevotella may influence the intestinal mucosal T cell response, highlighting the crosstalk between the gut microbiota and host immune system.6 The lamina propria and Peyer’s patches contains a large number of IL-17+CD4+ T (Th17) cells and Foxp3+ Treg cells, which represent a class of potent immunomodulatory effector cells. In particular, Th17 cells are a specific lineage of CD4+ TH cells that are essential for host defense Rabbit Polyclonal to PMEPA1 and play a key role in the development of autoimmune disease by producing the pro-inflammatory cytokines interleukin-17A (IL-17A), IL-17F and IL-22.9 The study in germ-free models has demonstrated that Th17 cells were induced upon colonization of commensal bacteria, especially for segmented filamentous bacteria (SFB).10,11 Further, Treg cells and Th17 cells can promote class switch of B cells and production of secreted IgA (SIgA), therefore contributing to compartmentalization of commensal microbiota and their homeostasis within local habitats.12, 13, 14 The coating of commensal bacteria and their soluble antigens by SIgA inhibits their binding to the intestine epithelium and penetration into the lamina propria.15 Thus, the production of SIgA is crucial for host-commensal mutualism maintenance and function of intestinal mucosal barrier in protection against pathogen invasion.16, 17, 18 Commensal bacteria can enhance intestinal epithelial cell barrier function through production of a diverse array of metabolites. For instance, short-chain fatty acids (SCFAs), namely acetate, propionate and butyrate, function as energetic substrates for epithelial cells. For example, acetate produced by O157:H7,19 while bacterially produced butyrate has been reported to regulate energy metabolism in intestinal epithelial cells (IECs), by serving as primary energy source for colonocytes.20 Gut microbiome’s role in (tumor microenvironment) TME Dysbiosis of microbial community usually induce the disruption of the intestinal barrier facilitating subsequent leakage of microbes and metabolites, which leads to chronic inflammatory state, lipid metabolism disorders, deregulation of growth of cells and impairment of the ability of myeloid cells in clearing mutant, senescent and malfunctioning cells, thereby promoting tumor outgrowth. Reconstitution of germ-free mice with patient-derived microbiota has revealed a mechanistic link between microbiota composition and anti-tumor immunity.21 Gut commensals-derived MAMPs or PAMPs can traverse the mucosal barrier, enter the circulation and reach to distant sites such as lymph nodes and tumor where a strong immune response is triggered.22 Recent studies suggested the concept of antigen cross-reactivity as a factor of augmenting anti-tumor immunity.21,23 Under this proposed model, Necrostatin 2 S enantiomer cross-reactive T cells primed against bacterial antigens might activate anti-tumor response either by providing help (CD4+ T cells) or through direct killing (CD8+ T cells). A pancreatic cancer-related study demonstrated that intra-tumoral and circulating T cells are responsive to both neoantigens and predicted cross-reactivity with microbial epitopes.23 Another candidate mechanism by which gut bacteria modulate anti-tumor immunity is through local induction of immunomodulatory cytokines released by host cells (such as gut epithelium or immune cells) that disseminate systemically. These cytokines, including TNF, TGF-, IL-12 and IL-10, may shift the threshold of immune subsets activation within.